204863-51-4

Basic information

• Product Name: Benzoic acid, 4-[(2-ethoxy-2-oxoethyl)thio]-3-nitro-
• CAS NO: 204863-51-4
• Molecular Formula: C11H11NO6S
• Molecular Weight: 285.277
• Mol File: 204863-51-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[(2-ethoxy-2-oxoethyl)thio]-3-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[(2-ethoxy-2-oxoethyl)thio]-3-nitro-(204863-51-4)
• EPA Substance Registry System: Benzoic acid, 4-[(2-ethoxy-2-oxoethyl)thio]-3-nitro-(204863-51-4)

Safety Data

• Hazardous Substances Data: 204863-51-4(Hazardous Substances Data)

Upstream product

• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 623-51-8 ethyl 2-sulfanylacetate 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 49706-71-0 bis(2-nitro-4-carboxyphenyl) disulfide 

Downstream Products

• 204863-52-5 ethyl 4-ethoxycarbonylmethylsulfanyl-3-nitrobenzoate 
• 1392139-29-5 (Z)-2-(3-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxylic acid 
• 1392138-98-5 C₂₄H₂₆FN₃O₂S 
• 1392138-99-6 C₂₆H₂₈FN₃O₄S 
• 1392139-00-2 C₂₁H₂₀FN₃O₂S 
• 1392139-01-3 C₂₀H₂₀FN₃O₂S 
• 1392139-08-0 C₂₂H₂₄FN₃O₂S 
• 1392139-15-9 C₂₂H₂₂FN₃O₂S 
• 1392139-18-2 C₂₃H₂₄FN₃O₂S 
• 1392139-19-3 C₂₂H₂₂FN₃O₃S 
• 1392139-21-7 C₂₃H₂₄FN₃O₂S 
• 1392139-22-8 (Z)-6-(3-aminopyrrolidine-1-carbonyl)-2-(2-fluorobenzylidene)-2H-benzo[b][1,4]thiazin-3(4H)-one 
• 1392139-42-2 C₂₅H₂₆FN₃O₄S 
• 1392139-23-9 C₂₃H₁₇FN₂O₂S 

Relevant articles and documents

MONOACYLGLYCEROL LIPASE INHIBITORS

Provided are compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof: Also provided are compositions comprising compounds of formula (I). The compounds and compositions are also provided for use as medicaments, for example as medicaments useful in the treatment of a condition modulated by monoacylglycerol lipase (MAGL). Also provided are the use of compounds and compositions for the inhibition of monoacylglycerol lipase (MAGL).

AMINE COMPOUNDS

The present invention provide a compound of the formula:wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrogen atom, etc.; R4 and R5 are the same or different and each represents a hydrogen, etc.; R6 represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.